x | RIVIA is the first Trial Intelligence platform with Agentic AI tools for modern sponsors. It brings all clinical and operational data into one single view, giving sponsors real-time control of the clinical development and saving up to 30% of the monitoring costs. All-in-one. All in real time. No more waiting on the CROs.
Polish Investment & Trade Agency
The Polish Investment and Trade Agency is a mission driven, government entity, that is dedicated to promoting and growing the economy of Poland on a global stage. Anchored in Warsaw, with a network of nearly 60 foreign trade offices around the world, the Agency’s mission is to increase the awareness of Polish brands in international markets and to promote national products and services. This mission is accomplished by three pillars: promoting Polish exports, supporting the inflow of foreign direct investments to Poland and the implementation of Polish investments in the country, and the cultivation of partnerships with domestic and international stakeholders. | . | The Polish Investment and Trade Agency (PAIH) is Poland’s leading government agency dedicated to promoting Polish business on the international stage and attracting foreign investment to Poland. As a key partner for international companies looking to explore opportunities in Poland, PAIH provides comprehensive support to exporters and investors, bridging connections between global markets and the dynamic Polish economy. At the BIO International Convention, PAIH proudly coordinates the Polish National Pavilion, a platform showcasing Poland’s innovation potential in the life sciences sector. In collaboration with BioForum Central European Life Science Cluster, this year’s booth features 26 outstanding Polish companies representing the strength, diversity, and international ambitions of Poland’s biotech ecosystem. At this year’s BIO International Convention, Polish exhibitors will present cutting-edge solutions across four key categories: Drug Development, Diagnostics, Manufacturing, and Digital Solutions and Services. We invite all BIO International Convention participants to visit the Polish National Booth, meet our innovative companies, and explore partnership opportunities across the biotech value chain—from early-stage research and diagnostics to digital transformation and advanced manufacturing. | xxxx
Pheiron GmbH
x | Pheiron is an AI research lab working towards a future of deterministic drug development. We can’t reliably predict which biology will work in humans. Pheiron builds causal models on primary human data to generate biological alpha: knowing what biology will work early enough to change the outcome of a drug program.
Phastar
Phastar is an award-winning biometrics and data science CRO, trusted by pharma, biotech, and medical device companies worldwide. With a global team of data specialists, we bring expertise, precision, and pace to every trial—because behind every data point is a patient waiting for treatment. We don’t just deliver on-time high quality data; we partner with you to turn complexity into clarity. Leveraging best-in-class technology, AI-enhanced analytics, advanced statistical methods, and deep therapeutic expertise, we accelerate regulatory approvals, ensure compliance with global standards and seamlessly mitigate risk. Our proven track record in transforming complex data into clear, actionable intelligence enables you to accelerate drug development. With scalable, tailored solutions, we expedite trials—bringing life-changing therapies to patients faster.
PharSafer
Founded in 2003 by Dr Graeme Ladds, PharSafer® is a specialist Contract Research Organisation (CRO) in Global Clinical and Post Marketing Drug Safety, and Medical Services, with a wealth of experience in Pharmacovigilance, Auditing and Medical Affairs – and the various, numerous and extensive legal safety/medical obligations for licence holders to comply with – as well as Regulatory Strategy for the best methods for obtaining scientific advice concerning licence submissions and approvals. Together with our sister company which focuses on Training: SaPhar, PharSafer® continuously seeks new and innovative ways to provide added value for our global clients – going above and beyond expectations and optimising processes and procedures involved with clinical and post marketing drug safety and licencing approach. Our ability to offer first-class services in Pharmacovigilance, Regulatory Affairs, Training, Auditing, Medical Affairs and IT Informatics means that, for many clients, we operate as their Pharmacovigilance and Medical Departments – guiding them through the labyrinth of drug safety and medical legislation, all in the interests of ensuring patient safety and client compliance. We love what we do. We love finding solutions. Quite simply, we are by far… Your leading partner in Drug Safety. | PharSafer is a Global CRO specialising in Clinical & Post Marketing Pharmacovigilance; Medical Affairs; Training; Auditing; IT Informatics and Regulatory Intelligence. PharSafer have been operating for the last 23 years growing annually and helping take Companies from their clinical to post-marketing phases and many clients have been with us over 10 years now. PharSafer have attended over 100 inspections on behalf of clients to aid their compliance and ensure Regulatory Authorities are satisfied with the activities being performed. PharSafer are also an innovative Company designing validated and automated systems to provide cost-effective solutions for clients and ensure Regulatory compliant systems. Our client base is truly global being in all continents and for clients that have drugs; devices; vaccines; biologics; advanced therapies; biosimilars; herbal and cosmetics. Our Team within the Company are very experienced (many with over 15 years experience) aided by our sister training Company (SaPhar) to provide new updates for clients on country specific regulations with regular monthly contacts and comments going to all clients. We would be happy to engage with you and talk about product development; product expansions into new countries; product launches and perform all of the activities mentioned above. Please review of website and we look forward to engaging with you personally.
PharmaCircle
PharmaCircle will be showcasing our Partnership Explorer, a new analysis tool that helps business development professionals to identify external innovation and partnering opportunities. With PharmaCircle’s Partnership Explorer, you can easily explore and evaluate partnered and unpartnered pipeline programs and products by a host of filters including product name, molecule/API name, target name, company name, indication/disease area, molecule/API type, target type, mechanism type, phase, route, country/region, drug delivery category, and dosage form. PharmaCircle’s business intelligence and prospecting tools explore the business portfolios, capabilities, and transactions of more than 32,000 commercial and emerging stage life sciences companies and suppliers from around the world. PharmaCircle’s search and analysis tools include the Partnership Explorer; Terminated Programs Tracker; Strategic Deals Analyzer; Venture Capital & Funding Tracker; Pipeline & Products Intelligence with Formulation Details; Product Sales, Forecast & Unit Pricing Data; Company Profile PDF Reports; Disease Area PDF Reports; Epidemiology Explorer; Trial Landscape Explorer; Patent Exclusivity Tracker; Drug Delivery Technology Analyzer; CMOCRO Explorer; Prospector Business Development Map Tool; Spyglass Personalized Weekly Email News Brief. Since 2003, PharmaCircle has been providing commercial and emerging stage life sciences companies and suppliers the integrated data, powerful analysis tools and industry knowledge needed to solve complex, real-world challenges in product development and innovation. To see how we can help you, please visit our booth #1243 or website www.pharmacircle.com | PharmaCircle will be showcasing Partnership Explorer, a powerful analysis tool that helps business development professionals to identify external innovation and partnering opportunities, and enhancements to our Professional Subscription Service of business intelligence and prospecting solutions. With PharmaCircle’s Partnership Explorer, you can easily explore and evaluate more than 25,000 unpartnered programs and products by a host of filters, identify country/regional licensing opportunities, and track in-licensed and out-licensed products for each company. PharmaCircle’s Professional Subscription Service includes Pipeline & Products Intelligence; Company Profile Reports; Strategic Deals Analysis; Venture Capital & Funding Tracking; Product Sales, Forecast & Pricing; Epidemiology Explorer; Orphan Drug Analytics, Trial Landscape Explorer; Prospector Business Development Map Tool; CMOCRO Explorer; News & Insights; and Spyglass Personalized Weekly Email News Brief. PharmaCircle’s business intelligence and prospecting tools provide a comprehensive view of the business portfolios, capabilities, deals and funding transactions of more than 35,000 commercial and emerging stage life sciences companies and suppliers from around the world. Since 2003, PharmaCircle has been providing commercial and emerging stage life sciences companies and suppliers the integrated data, powerful analysis tools and industry knowledge needed to solve complex, real-world challenges in product development and innovation. To see how we can help you, please visit our booth #4155 or website www.pharmacircle.com. | PharmaCircle provides the curated data, powerful analysis tools and industry knowledge needed to solve complex, real-world challenges in drug product development and innovation. PharmaCircle’s search and evaluation tools identify unpartnered pipeline program opportunities and examine the pipeline/product portfolios and business transactions of commercial and emerging stage life sciences companies and their suppliers. PharmaCircle has been curating pharma pipeline intelligence, formulation/drug delivery information, and supply chain insights for more than 20 years. Our team of product developers and customer support personnel is comprised of scientists and business analysts from the life sciences industry. Many life sciences innovators and manufacturers rely on PharmaCircle’s curated content and expert analyses for mission-critical projects, and reference our data in conference presentations and published articles.
Owkin
Owkin is an Agentic AI company pioneering the use of data, biology, and AI to decode the fundamental mechanics of disease and advance medical science. By focusing on the system’s ability to uncover biology’s ground truth at scale, Owkin aims to revolutionize the way we diagnose and treat diseases. With a vision of achieving a “positive singularity” in medicine, Owkin leverages AI to deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional pharmaceutical approaches often cannot solve. Owkin also founded MOSAIC, the world’s largest spatial multi-omics atlas for cancer research across nine cancer indications. Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like F-Prime, GV and Bpifrance, among others.
NEUROPHET
NEUROPHET Inc., Seoul, Republic of Korea, with expertise in neuroscience. We have been focusing on developing and providing innovative medical solutions for helping patients suffering from neurological diseases. To achieve the mission, we have applied state-of-the-art AI technologies to our expertise in neuroimaging, brain modeling and neuromodulation. We are conducting research in imaging-based biomarkers for Alzheimer’s disease (AD), which will be valuable tool for clinical trials (surrogate biomarker for drug response and disease progression) and companion diagnostics for AD therapeutics and furthermore, global standardization for AD staging and diagnostics. Neurophet provides medical-grade solutions approved by international regulatory bodies. | Neurophet Inc. develops advanced AI-powered neuroimaging solutions to enhance the diagnosis, monitoring, and treatment planning of neurological disorders. Its flagship products—AQUA AD, AQUA, and SCALE PET—deliver precise, quantitative insights into brain atrophy, lesion dynamics, and imaging biomarkers, including those associated with amyloid-targeted therapeutics (ATT) and amyloid-related imaging abnormalities (ARIA), through MRI and PET imaging. | Neurophet is a specialized company developing AI-powered brain imaging analysis solutions and therapeutic medical devices, covering the full cycle of neurological care — from MRI and PET analysis to wearable brain stimulation devices. We support medical institutions with AI-based imaging for diagnosis and treatment monitoring, and provide standardized central imaging services for global pharmaceutical clinical trials through our Imaging Core Lab (ICL). From the clinical frontline to global clinical trials, Neurophet is advancing as a global leader in neurological imaging analysis.